Landscapes / Companies
Vir Biotechnology, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 3
1 in Phase 2
Drugs
4
in active trials · 10 in all
Trials
6 active
21 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Small interfering RNA |
Phase 3 | Dec 2026Phase 3 trial completes | |||
| How it works | A short strand of RNA that switches off one gene | ||||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Viral Hepatitis, Hepatitis D, Chronic | ||||
| Open drug page | |||||
Artificial immunoglobulin |
Phase 3 | Dec 2026Phase 3 trial completes | |||
| How it works | An antibody | ||||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Viral Hepatitis, Hepatitis D, Chronic | ||||
| Open drug page | |||||
— |
Phase 1/2 | Apr 2028Phase 1/2 trial completes | |||
| Next date | Apr 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Locally Advanced or Metastatic HER2-Expressing Cancers | ||||
| Open drug page | |||||
— |
Phase 1 | Aug 2029Phase 1 trial completes | |||
| Next date | Aug 2029 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumor Malignancies, EGFR Positive Solid Tumors and 1 more | ||||
| Open drug page | |||||
About
- No active trial
- 6 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021